{"name":"Research in Real-Life Ltd","slug":"research-in-real-life-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"oncology","drugs":[{"name":"Extra-fine hydrofluoroalkane beclometasone dipropionate","genericName":"Extra-fine hydrofluoroalkane beclometasone dipropionate","slug":"extra-fine-hydrofluoroalkane-beclometasone-dipropionate","indication":"Asthma","status":"phase_2"},{"name":"Extra-fine hydrofluoroalkane-beclomethasone dipropionate","genericName":"Extra-fine hydrofluoroalkane-beclomethasone dipropionate","slug":"extra-fine-hydrofluoroalkane-beclomethasone-dipropionate","indication":"Asthma","status":"phase_2"},{"name":"Chlorofluorocarbon beclomethasone dipropionate","genericName":"Chlorofluorocarbon beclomethasone dipropionate","slug":"chlorofluorocarbon-beclomethasone-dipropionate","indication":"Asthma (maintenance and reliever therapy)","status":"phase_2"},{"name":"Chlorofluorocarbon beclomethasone metered dose inhaler","genericName":"Chlorofluorocarbon beclomethasone metered dose inhaler","slug":"chlorofluorocarbon-beclomethasone-metered-dose-inhaler","indication":"Asthma","status":"phase_2"},{"name":"Extra-fine hydrofluoroalkane beclomethasone MDI","genericName":"Extra-fine hydrofluoroalkane beclomethasone MDI","slug":"extra-fine-hydrofluoroalkane-beclomethasone-mdi","indication":"Asthma","status":"phase_2"},{"name":"Fluticasone 125/formoterol 5","genericName":"Fluticasone 125/formoterol 5","slug":"fluticasone-125-formoterol-5","indication":"Asthma maintenance therapy","status":"marketed"},{"name":"Fluticasone 250/formoterol 10","genericName":"Fluticasone 250/formoterol 10","slug":"fluticasone-250-formoterol-10","indication":"Asthma maintenance therapy","status":"marketed"},{"name":"Fluticasone 250/salmeterol 25","genericName":"Fluticasone 250/salmeterol 25","slug":"fluticasone-250-salmeterol-25","indication":"Asthma maintenance therapy","status":"marketed"},{"name":"Fluticasone propionate metred dose inhaler","genericName":"Fluticasone propionate metred dose inhaler","slug":"fluticasone-propionate-metred-dose-inhaler","indication":"Maintenance treatment of asthma","status":"phase_2"},{"name":"Qvar (100 mcg)","genericName":"Qvar (100 mcg)","slug":"qvar-100-mcg","indication":"Asthma maintenance therapy in adults and children","status":"marketed"}]}],"pipeline":[{"name":"Extra-fine hydrofluoroalkane beclometasone dipropionate","genericName":"Extra-fine hydrofluoroalkane beclometasone dipropionate","slug":"extra-fine-hydrofluoroalkane-beclometasone-dipropionate","phase":"phase_2","mechanism":"Beclometasone dipropionate is a corticosteroid that works by reducing inflammation in the body.","indications":["Asthma","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Extra-fine hydrofluoroalkane-beclomethasone dipropionate","genericName":"Extra-fine hydrofluoroalkane-beclomethasone dipropionate","slug":"extra-fine-hydrofluoroalkane-beclomethasone-dipropionate","phase":"phase_2","mechanism":"Glucocorticoid receptor agonist","indications":["Asthma"],"catalyst":""},{"name":"Chlorofluorocarbon beclomethasone dipropionate","genericName":"Chlorofluorocarbon beclomethasone dipropionate","slug":"chlorofluorocarbon-beclomethasone-dipropionate","phase":"phase_2","mechanism":"Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs.","indications":["Asthma (maintenance and reliever therapy)","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Chlorofluorocarbon beclomethasone metered dose inhaler","genericName":"Chlorofluorocarbon beclomethasone metered dose inhaler","slug":"chlorofluorocarbon-beclomethasone-metered-dose-inhaler","phase":"phase_2","mechanism":"Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and airway hyperresponsiveness.","indications":["Asthma","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Extra-fine hydrofluoroalkane beclomethasone MDI","genericName":"Extra-fine hydrofluoroalkane beclomethasone MDI","slug":"extra-fine-hydrofluoroalkane-beclomethasone-mdi","phase":"phase_2","mechanism":"Glucocorticoid receptor agonist","indications":["Asthma","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Fluticasone 125/formoterol 5","genericName":"Fluticasone 125/formoterol 5","slug":"fluticasone-125-formoterol-5","phase":"marketed","mechanism":"Fluticasone/formoterol is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Fluticasone 250/formoterol 10","genericName":"Fluticasone 250/formoterol 10","slug":"fluticasone-250-formoterol-10","phase":"marketed","mechanism":"Fluticasone/formoterol is an inhaled combination of a corticosteroid and a long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Fluticasone 250/salmeterol 25","genericName":"Fluticasone 250/salmeterol 25","slug":"fluticasone-250-salmeterol-25","phase":"marketed","mechanism":"Fluticasone/salmeterol is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Fluticasone propionate metred dose inhaler","genericName":"Fluticasone propionate metred dose inhaler","slug":"fluticasone-propionate-metred-dose-inhaler","phase":"phase_2","mechanism":"Fluticasone propionate is a corticosteroid that works by reducing inflammation in the lungs.","indications":["Maintenance treatment of asthma","Treatment of allergic rhinitis"],"catalyst":""},{"name":"Qvar (100 mcg)","genericName":"Qvar (100 mcg)","slug":"qvar-100-mcg","phase":"marketed","mechanism":"Qvar is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","indications":["Asthma maintenance therapy in adults and children"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE9iSmZ5bXBtOU5hRjFKRWlEQWZ4MDNocldwV2NZRHNRdmk5SF95VnB1TjRXNnYzTFhVSlpFcFpVZ0p0MFYxTUpVag?oc=5","date":"2026-04-08","type":"pipeline","source":"MEXC","summary":"Snap Inc. (SNAP) Stock; Edges Higher as Health Ad Push Targets Pharma Budgets - MEXC","headline":"Snap Inc. (SNAP) Stock; Edges Higher as Health Ad Push Targets Pharma Budgets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE80ekdfUDFkSFd6azRmWHN4ekk4cFNlSEdIRF9LQmFzLW1Bb3pfeHYzODFqTXZ0TkE2NFZzYUV0TzlGTms5VjlYYUhXWGhrMUJUOTk5S3FHamdBQQ?oc=5","date":"2026-04-03","type":"pipeline","source":"AIMultiple","summary":"25 Healthcare AI Use Cases with Examples - AIMultiple","headline":"25 Healthcare AI Use Cases with Examples","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQdjZvSV9rd0tISlJ0U0l5MkdaYURuRmUtTV9NQ0hEeDFJZWJfRl9raGVLcTlsOEgzSlFDdVNzS012S3pSbnNNZE85Z25KT2JvelVjVm5nMXpxbzZ2NEVvZmxZRXh6YU5qNFNjc2xpUVAxbTBoOUhPQkhIX0ZPRVJfMWdmOTAwNTdpeThaSmpNSEVYek9vVGVCcEhzOVhSZ2VQempFNVZ5Ri1nUEJ5cUtzXzBBbUNZRWJVbkRyT2dZcVRCa2tMSHU5RjVHU3c4TFo0MnljaFAtZE5GalBha2R0QTdVN01BWm92WmlnV1I3eGtrdw?oc=5","date":"2026-03-27","type":"pipeline","source":"PR Newswire","summary":"Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting - PR Newswire","headline":"Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOa292Y3l3VFdzZ2h1SHhxLUVSVlI1OFozaUdEYW9qUEh3Z3pBMmRHVDV6N0draUFsOHFmQW5OVVBaRVpTRHhjZTVxcHNhSXRpNEx3UjhtU1IzTjBTNmtlT05OMHpnTWJRQlA0bktWUEl6X3ZsSklPdS1DalRpa05HcEhhS0xxdURUMVR0VjM3UzhvTzc0dEkxa2VhakVjTkFtWXp6R1ZPZlJ4UjhKOC1nOE1Xc2xSNURTYlRTMk5QQWZ5ODhKTzFoSlJyU2RGUzZydGc?oc=5","date":"2026-03-25","type":"trial","source":"clinicalleader.com","summary":"From Real-World Data To Real-World Impact Building The Evidence Capability Pharma Actually Needs - clinicalleader.com","headline":"From Real-World Data To Real-World Impact Building The Evidence Capability Pharma Actually Needs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNckdGeWRXRHpvNm1hdHJsdW4zZ3BqU0tmZGEyakM3ZjlwQUtZd3lVN1FpdnJXS2ZUZFJiTV9zdzlQOGVjSjQwbVlxRmxvUDJodHlJQ2Vfc1lKMGFqNW1HYTlZT185VC1UeE8xSmpBM1NRTUlackZRX3pwZW5mM0xpQW1TbENRd3hjdG42X3dTVEtoRGttNloxbXRuSkhybVZXU0x1NWFUOGk4X3Vsc05CQWpfcw?oc=5","date":"2026-03-18","type":"trial","source":"Stock Titan","summary":"Turning hospital data into drug insights: OneMedNet joins Navidence - Stock Titan","headline":"Turning hospital data into drug insights: OneMedNet joins Navidence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPeWlwUUwxbXVsTndOWWZJcE54MGNUNS10c3RFR3VKS2kzU1lHLTJVcnNLTjd1Q3FIVExRU1QwWTB1UU1vVlV3U3phSmkxc0lDS09DVkdMLWxjWTY4M0Y3YmxVdDJMcUJscGZuUW9MMmJINFNzU0wxbl9pQ1VUX1dEeUhhaFZvZmNQOG9sbjN6U3RqcDNIUmRfM282VVotakROLU1IMTZkeG9sMWltWExMVGZBd1ZlZGQ1ckxfNkJmRFVmblBKMFlvd0s0VzBtRktwS0JjX2pDaUExMFpMZjlqa2htd0E0bHFsWHUxN3QyM1E5UlphS2hTU29GZFk0VzdqUXVmY0xvUlRKdlB4OWc?oc=5","date":"2026-03-04","type":"deal","source":"GlobeNewswire","summary":"Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewswire","headline":"Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOcmtEbi15YXhTeHY1NUpEVHVYNnllR1llMGJpSVE4QmFNcU9XYTZJV0h4YVdWOW5EWjJQNG5nMXA1R1ppRFBHX2lnYk1Jd1MwMzRnY0cxeVBHRE54bVJQTHBIbG9qWkZfdkFuWU9QMU5IVlRLRjE1cW1SbWFfSjNMWU5CQTlUZTF6anBYai16UDdfcERWWG5Sa25rYXhhWVo0QW9mSWpabnhPQ0Y0OWJGS1FqYTBuOUN0OTlqZW5mRDRlQkhMTFJzQk9oNnRycWRCakRGek1vRnppV2xpeVdmSjJfNTdIWll1YXZEZFUzanloODlWX1NTbWhuNHh0VncxTy1NR3VEdUJVQUk?oc=5","date":"2026-02-17","type":"regulatory","source":"Investing News Network","summary":"NRx Pharmaceuticals Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 Following Type C FDA Meeting - Investing News Network","headline":"NRx Pharmaceuticals Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNQnJrWEFjTTZXa3FNcUZwNElmN0ZXZ3MydS16b21WU2VkWWwxTmtGUGxabnZlLUVldkxQTWVIZmlrY0d3TDlCbmhQWVFyTkpTWkpIeUlOX3o5ZkpWU1RCVUVmWTBRMC1jMkVEakhxakpweVloVndNRmY4MWhrMV9MQWVzT1RDQ3BPTnI2OEQyLUlkNUdOYjN6bEJ2b0VBclAxTGtSTmxhbE01NnlSYW5wTHlQSmtJaDNkaUdhRVF0dUd4OG5QU2c?oc=5","date":"2026-02-11","type":"trial","source":"Contract Pharma","summary":"Thermo Fisher, Datavant to Partner on Linking Real-World Data to Clinical Research - Contract Pharma","headline":"Thermo Fisher, Datavant to Partner on Linking Real-World Data to Clinical Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNUF9UWFhWX1k1djJ2V1RyS3ZnWFVrTVhpZ3QxZjNyU0VkazY4YzBUeDJBbFNyc0lBZkdDRG5jUThUV1hvTEV2ZEIzNkdUakhsOEdlNERtUVhVTUVudUE4NlZ3QW4tZlVoa0cwQ01LNzBnZWxROGFjYldiVnJRdVZ1UGRKdnR5Wk82eHZSRWg4bml3bzZseVdfZ1NaS3VjWmRPRHJyOUJacnkzTEhxWE5FZ21oa0UxT1YxT193ZUxCYw?oc=5","date":"2026-02-10","type":"pipeline","source":"The City of Covington, KY (.gov)","summary":"How Covington Is Shaping the Future of Healthcare and Life Sciences Innovation - The City of Covington, KY (.gov)","headline":"How Covington Is Shaping the Future of Healthcare and Life Sciences Innovation - The City of Covington, KY (.gov)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPRDJicXlCZVNWN0tubUlKcWdrbVNqOGRNZkxKeUhDaTZ5TS01aElkLXV0Vm9GU2g1cU9oVTZXcWk0YkxGa0xlUXJSMGRqY0lHY0twdnk4TUdQR2h3cTRQbFB1X0U1MXF1dnpzV3dZZ1B4NDhWQnZJU0Q0bTFraVJsbHBmazd1cEZmMHRkS3R1QU90TDdBeWZKR3ZBX01hQzRZQ2liZ05vRXgyQQ?oc=5","date":"2026-01-28","type":"deal","source":"pharmexec.com","summary":"Eli Lilly Enters $1 Billion Research Collaboration with Seamless Therapeutics | PharmExec - pharmexec.com","headline":"Eli Lilly Enters $1 Billion Research Collaboration with Seamless Therapeutics | PharmExec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNNFJvME1GSXhva0VhdFRQT2VmdEhSOWNLR1BzWDUwRV9JZVFTb3NMZUY4T1lOWWJQbGJnUGRvaEt6dEFnSGVCZ054U0pKZENnUXBTX181N2JjVHdnMGU4aDZULW1yV3ZBNzZlNXJmYndVUDQ4RzQwcHUtVjhTaWFLZTJGaW5OM2hyZ1hXcmlVS2R2Umc2cU04cXY0Ui1yRW5ZV3ROWkxlVDE4VFVLbTdpV2dGX0c2U3FXWjNHakc5Q0poYlZZeHNENnMzVHhGZw?oc=5","date":"2025-10-09","type":"pipeline","source":"IQVIA","summary":"Integrated Research: Why Pharma Leaders Are Flipping the Insights Playbook - IQVIA","headline":"Integrated Research: Why Pharma Leaders Are Flipping the Insights Playbook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQSDhxOEtDd1RUcHBYWDJLSGV4aXZvblA2WUpYWUlNc2pjSk1HNnlDMU0zUFZxTS1FU1Y4Mk1wQTRPY0JEeWxTSG40Q2lWcTVLc2pDc09pUWhBS3c3V1NUNGRQc3JUaTdUMVZNaFdvYXBBaDh6bkdaRVhEWENIdDRtMkpZYzZwektZaVBhT3JQUThwMUdiOVJTTzBlOGs2Q3c?oc=5","date":"2025-09-03","type":"pipeline","source":"EPAM","summary":"Real-World Evidence Accelerating Pharma Innovation in Switzerland - EPAM","headline":"Real-World Evidence Accelerating Pharma Innovation in Switzerland","sentiment":"neutral"}],"patents":[],"drugCount":10,"phaseCounts":{"phase_2":6,"marketed":4},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}